Global /United States /Healthcare /Biotechnology /NEVI
chevron_leftBack
Nevis Brands Inc. logo

Nevis Brands Inc.

NEVI
CSE: NEVI Delayed
0.0250CAD -17%
0.0179 USD
As of 13 June 2026, Nevis Brands Inc. has a market cap of $1.01M USD, ranking #48495 globally and #6226 in the United States. It ranks #4302 in the Healthcare sector, and #836 in the Biotechnology industry.
Global Rank
48495
Country Rank
6226
Sector Rank
4302
Industry Rank
836
Key Stats
Market Cap
$1.01MUSD
1.42M CAD
Enterprise Value
$1.27MUSD
1.77M CAD
Revenue (TTM)
$1.21MUSD
1.7M CAD
EBITDA (TTM)
$103.9KUSD
144.96K CAD
Net Income (TTM)
-$196.77KUSD
-275.07K CAD
EBITDA Margin
8.5%
Profit Margin
-16%
PS Ratio
0.8
PB Ratio
1.5
EV/EBITDA
12.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
John Kueber open_in_new
Employees
2
Website
nevisbrands.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-17% -17% -29% -44% -62% -50%

News

Loading...

Markets

Exchange Ticker Price
Canadian Securities Exchange
MIC: XCNQ
PRIMARY
NEVI
Nevis Brands Inc
ISIN: CA64155A1066
Shares Out.:
39.663M1 Shares Float: 35.513M2
TV:
SA:
YF:
GF:
BA:
MS:
0.0250 CAD
Cboe Canada
MIC: NEOE
NEVI
Nevis Brands Inc
ISIN: CA64155A1066
TV:
SA:
YF:
GF:
BA:
MS:
0.0450 CAD
OTC Markets
MIC: OTCM
NEVIF
Nevis Brands Inc
ISIN: CA64155A1066
TV:
SA:
YF:
GF:
BA:
MS:
0.0480 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Nevis Brands Inc.

Nevis Brands Inc. engages in the development and sale of cannabis products in the United States. It offers hemp derived THC beverages under the Major brand name. The company was formerly known as Pascal Biosciences Inc. and changed its name to Nevis Brands Inc. in June 2023. Nevis Brands Inc. is headquartered in Seattle, Washington.

Similar Companies

Industry: Biotechnology (United States)
Name
Market Cap diff.
PE
AMGN
$182.42B
18M%
23.9
GILD
$159.92B
16M%
19.0
NTRA
$27.6B
3M%
-
$26.3B
3M%
20.0
$25.03B
2M%
20.4
MRNA
$18.13B
2M%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
ARGX
$47.84B
41.39B EUR
5M%
39.9
$44.84B
68.19T KRW
4M%
35.5
CSL
$42.36B
60.27B AUD
4M%
29.3
LONN
$42.3B
33.71B CHF
4M%
37.2
068270
$28.11B
42.76T KRW
3M%
43.8
BNTX
$25.69B
3M%
-
chevron_leftBack